Can Preoperative Modified Systemic Inflammation Score (mSIS) Be Used to Predict Malignancy in Persistent Nondiagnostic Thyroid Nodules?

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2021 Feb 7

PMID 33550761

Citations 1

Authors

Hakan Atas

Birol Korukluoglu

Bulent Comcali

Nese Yaksi

Baris Saylam

Mesut Tez

Affiliations

Soon will be listed here.

Abstract

Background/aim: Despite the use of ultrasound guidance, a significant part of thyroid biopsies are nondiagnostic (ND). We aimed to investigate the utility of the preoperative modified systemic inflammation score (mSIS) to predict malignancies in patients with persistent ND thyroid nodules (TNs).

Materials And Methods: Records of 924 patients underwent thyroidectomy between September 2016 and May 2019 were retrospectively reviewed. The calculation of mSIS was as follows: mSIS 0 [patients with albumin (ALB) ≥ 4.0 g/dL and lymphocyte to monocyte ratio (LMR) ≥ 3.4], mSIS 1 [ALB < 4.0 g/dL or LMR < 3.4], and mSIS 2 [ALB < 4.0 g/dL and LMR < 3.4].

Results: One hundred and thirty-six patients were included in the study. Of the patients with a median age of 49 (21–81) years, 26 (19.1%) were male, and 110 (80.9%) were female. Besides low lymphocyte count (P = 0.03), and ALB levels (P < 0.01), higher BMI (P = 0.02) were also associated with malignancy. In patients classified as mSIS 2, 1 and 0; malignancy rates were 100%, 25.8%, and 16.1%, respectively. The association between preoperative mSIS and thyroid malignancies was statistically significant (P < 0.01).

Conclusion: We recommend that when patients with persistent ND TNs are assigned to mSIS 2 or 1, surgery should not be delayed due to the risk of malignancy.

Citing Articles

Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review.

Gradel K J Clin Med. 2023; 12(19).

PMID: 37834777 PMC: 10573484. DOI: 10.3390/jcm12196132.

References

Suzuki Y, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kondo T . Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg. 2016; 267(3):527-531. DOI: 10.1097/SLA.0000000000002115. View

Nishijima T, Muss H, Shachar S, Tamura K, Takamatsu Y . Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis. Cancer Treat Rev. 2015; 41(10):971-8. DOI: 10.1016/j.ctrv.2015.10.003. View

Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kimura K . The prognostic value of the systemic inflammatory score in patients with unresectable metastatic colorectal cancer. Oncol Lett. 2018; 16(1):666-672. PMC: 6006478. DOI: 10.3892/ol.2018.8628. View

Baser H, Topaloglu O, Faki S, Alkan A, Yazicioglu M, Tatli Dogan H . Evaluation of malignancy with thyroid imaging reporting and data system (TI-RADS) in thyroid nodules with persistent nondiagnostic cytology. Turk J Med Sci. 2019; 49(3):907-913. PMC: 7018230. DOI: 10.3906/sag-1811-198. View

Yoon J, Lee H, Kim E, Moon H, Kwak J . Thyroid Nodules: Nondiagnostic Cytologic Results according to Thyroid Imaging Reporting and Data System before and after Application of the Bethesda System. Radiology. 2015; 276(2):579-87. DOI: 10.1148/radiol.15142308. View

Mantovani A, Allavena P, Sica A, Balkwill F . Cancer-related inflammation. Nature. 2008; 454(7203):436-44. DOI: 10.1038/nature07205. View

Kanda M, Koike M, Tanaka C, Kobayashi D, Hattori N, Hayashi M . Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus. Ann Surg Oncol. 2019; 26(13):4773-4781. DOI: 10.1245/s10434-019-07914-7. View

Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133. PMC: 4739132. DOI: 10.1089/thy.2015.0020. View

Jackson D, Handelsman R, Farra J, Lew J . Increased Incidental Thyroid Cancer in Patients With Subclinical Chronic Lymphocytic Thyroiditis. J Surg Res. 2019; 245:115-118. DOI: 10.1016/j.jss.2019.07.025. View

10.

Lin J, Lin J, Xie J, Wang J, Lu J, Chen Q . Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer. Gastric Cancer. 2018; 22(2):403-412. DOI: 10.1007/s10120-018-0854-6. View

11.

Ghoshal A, Garmo H, Arthur R, Carroll P, Holmberg L, Hammar N . Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum. Oncotarget. 2018; 9(1):774-782. PMC: 5787509. DOI: 10.18632/oncotarget.22891. View

12.

Liu B, Huang Y, Sun Y, Zhang J, Yao Y, Shen Z . Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep. 2016; 6:39862. PMC: 5180218. DOI: 10.1038/srep39862. View

13.

Yokota M, Katoh H, Nishimiya H, Kikuchi M, Kosaka Y, Sengoku N . Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer. J Surg Res. 2019; 246:535-543. DOI: 10.1016/j.jss.2019.09.034. View

14.

Son H, Lee H, Kang K, Lee I . The risk of thyroid cancer and obesity: A nationwide population-based study using the Korea National Health Insurance Corporation cohort database. Surg Oncol. 2018; 27(2):166-171. DOI: 10.1016/j.suronc.2018.03.001. View

15.

Atas H, Korukluoglu B, Altun Ozdemir B, Yaksi N, Saylam B, Tez M . Diagnostic value of modified systemic inflammation score for prediction of malignancy in patients with indeterminate thyroid nodules. Am J Surg. 2020; 221(1):117-121. DOI: 10.1016/j.amjsurg.2020.08.002. View

16.

Chang Y, An H, Xu L, Zhu Y, Yang Y, Lin Z . Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma. Br J Cancer. 2015; 113(4):626-33. PMC: 4647686. DOI: 10.1038/bjc.2015.241. View

17.

Li N, Fu S, Cui M, Niu Y, Li B, Liu Z . Platelet Distribution Width and Serum Albumin Levels for Discrimination of Thyroid Cancer From Benign Thyroid Nodules. Asian Pac J Cancer Prev. 2017; 18(7):1773-1777. PMC: 5648378. DOI: 10.22034/APJCP.2017.18.7.1773. View

18.

Kocer D, Karakukcu C, Karaman H, Gokay F, Bayram F . May the neutrophil/lymphocyte ratio be a predictor in the differentiation of different thyroid disorders?. Asian Pac J Cancer Prev. 2015; 16(9):3875-9. DOI: 10.7314/apjcp.2015.16.9.3875. View

19.

Cibas E, Ali S . The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27(11):1341-1346. DOI: 10.1089/thy.2017.0500. View